TG Therapeutics, Inc. (TGTX) has a market capitalization of $5.52B and trades at $34.56. The 52-week range is 25.28-46.48.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 11.1, Earnings Per Share (EPS) of $3.10, annual revenue of $616.29M.
The stock has a beta of 1.76, operates in the Healthcare sector.
